The lack of large-sample studies evaluating the expression of different ER isoforms using isoform-specific antibodies (ERα, ERβ, and GPER) likely contributes to the inconsistency of published results concerning ERs expression in PAAD [9]. Here, GPER1 is linked to pancreatic adenocarcinoma.